Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1403897

Cover Image

PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1403897

Middle East And Africa Cardiac Monitoring - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4750
PDF (Team License: Up to 7 Users)
USD 5250
PDF (Site License)
USD 6500
PDF (Corporate License)
USD 8750

Add to Cart

Middle East And Africa Cardiac Monitoring - Market - IMG1

The Middle East And Africa Cardiac Monitoring Market size is estimated at USD 1.19 billion in 2024, and is expected to reach USD 1.38 billion by 2029, growing at a CAGR of 3.22% during the forecast period (2024-2029).

Key Highlights

  • COVID-19 had a significant impact on the growth of the market initially, as there were various lockdown restrictions imposed in the region. For instance, according to the study published by PubMed in April 2021, patients infected with COVID-19 were highly prevalent with cardiovascular diseases in Saudi Arabia. The major risk factors associated with these diseases in COVID-19 patients were pneumonia and increased length of stay in the hospital. This study suggested that COVID-19 patients were at higher risk of cardiovascular diseases, which expectedly led to more adoption of cardiac monitoring devices. Thus, the pandemic affected the market significantly in the initial phase. Also, during the post-pandemic period, the increasing adoption of cardiac monitoring in the Middle East and Africa region is expected to contribute to the growth of the market.
  • The market is driven by an increase in the prevalence of heart diseases, a growing aging population who are very susceptible to coronary heart diseases, and improved efficiency of devices. Countries in the Middle East and Africa have a high incidence of cardiac diseases. The rate of diagnosis of cardiovascular diseases is increasing over time due to the high incidence rate of cardiac diseases and the need to control the mortality rate through early diagnosis and treatment for cardiovascular disease with the help of cardiac monitoring devices. Hence, a rise in the incidence of cardiovascular diseases drives the market.
  • Moreover, according to the United Nations Population Fund's World Population Dashboard's Statistics 2022, in the United Arab Emirates, approximately 2% of the population of the country is aged 65 years and above. In addition, as per the same source, approximately 4% of the population of the country will be aged 65 years and above in 2022. As the geriatric population is prone to suffer from various chronic diseases such as cardiovascular diseases, the anticipated increase in population is expected to fuel the demand for patient monitoring. Other factors, such as investments in R&D for innovative product development, ease of use and portability in devices, and the demand for home-based, point-of-care, and remote monitoring cardiac systems, are the major drivers for the market.
  • However, the rising rate of infections due to these devices has tremendous economic implications for hospitals.

Middle East And Africa Cardiac Monitoring Market Trends

ECG Monitor is Expected to Hold a Significant Share in the Cardiac Monitoring Market Over the Forecast Period

  • The electrocardiogram (ECG monitor segment is expected to hold a significant share in the growth of the market over the forecast period due to the increasing incidence of cardiovascular diseases and technological advancements. The increase in the incidence of cardiovascular diseases (CVD) necessitates the need for long-term ECG monitoring in patients, which is the major factor driving the adoption of ECG monitors.
  • For instance, according to an article published by PLOS ONE in December 2022, heart diseases and stroke are the first leading cause of death in Kuwait, and the suboptimal diet low in fruits, vegetables, whole grains, nuts, and seeds, and high in processed meats, red meats, and sugar-sweetened beverages (SSBs), contributes to the highest number of deaths from non-communicable diseases such as cardiovascular diseases. Such increasing cardiovascular disease risks are expected to contribute to the growth of the studied segment during the forecast period.
  • Moreover, the geriatric population is often associated with an increased risk of cardiovascular diseases. Thus, the rising geriatric population in the region is a major factor that is expected to drive the adoption of ECG monitors. For instance, according to an article published by the International Institute on Ageing in February 2022, it is estimated that older adults in the Arab world are expected to increase in number and percentage of the general population. The source also stated that all MENA countries are likely to undergo marked changes from 2025, with those aged above sixty-four years representing the largest age group by 2050.
  • Usually, ECG monitors are used in hospitals. However, with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely and on time. The increasing product launches of ECG monitors in the Middle East and Africa are expected to contribute to the growth of the studied segment. For instance, in July 2022, Huawei launched a wrist type of ECG and blood pressure monitoring device, the Watch D, in the United Arab Emirates (UAE).
  • Thus, the above-mentioned factors, such as the increasing product launches, the rising geriatric population, and the rising prevalence of cardiovascular diseases, are expected to contribute to the growth of the studied segment during the forecast period.
Middle East And Africa Cardiac Monitoring - Market - IMG2

GCC is is Expected to Hold a Significant Share in the Middle East and Africa Cardiac Monitoring Market Over the Forecast Period

  • The Gulf Cooperation Council (GCC) comprises six countries: Saudi Arabia, Kuwait, Bahrain, Qatar, the United Arab Emirates (UAE), and Oman. Factors such as the growing burden of diseases in these countries, rising technological innovation, growing geriatric population, product launches, and strategic initiatives by market players, along with the increasing research and development expenditure, will drive the studied market growth during the study period.
  • The increase in research and development expenditure and the presence of cardiac centers are also expected to drive the growth of the Middle East and African cardiac monitoring market. For instance, according to the data published by the Ministry of Health of Saudi Arabia in 2021, there are approximately 10 cardiac centers present in the country.
  • Moreover, the prevalence of various risk factors for developing cardiovascular diseases and the rising geriatric population in the region is expected to drive the growth of the market in this region. According to an article published by the Obesity Society in September 2022, a research model was formed which predicted that 80.07% of female United Arab Emirates nationals will become overweight or obese and 60.19% will be obesity by 2070, and the population with abnormal eating behavior will increase to 15% by 2070. Such a prevalence of obesity is expected to drive the demand for cardiac monitoring in the GCC region, thereby contributing to the growth of the market.

Middle East And Africa Cardiac Monitoring Industry Overview

The studied market is moderately consolidated in nature and consists of a few major players. The companies have been following various strategies such as acquisitions, partnerships, investments in research activities, and new product launches to sustain themselves among the competitors in the market. The major players include GE Healthcare, Medtronic, Abbott Laboratories, Boston Scientific Corporation, etc. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 52600

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Incidences of Cardiovascular Diseases
    • 4.2.2 Advancements in the Technology
  • 4.3 Market Restraints
    • 4.3.1 Unfavourable Reimbursement Policies and Risk of Infection Due to Implantable Monitoring Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Device Type
    • 5.1.1 ECG Monitor
    • 5.1.2 Event Recorder
    • 5.1.3 Implantable Cardiac Loop Recorder
    • 5.1.4 Pacemaker
    • 5.1.5 Smart Wearable
    • 5.1.6 Other Device Types
  • 5.2 By End-users
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Home Care Settings
    • 5.2.3 Others End-users
  • 5.3 Geography
    • 5.3.1 GCC
    • 5.3.2 South Africa
    • 5.3.3 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic PLC
    • 6.1.2 Abbott Laboratories
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 GE Healthcare
    • 6.1.5 Biotronik
    • 6.1.6 iRhythm Technologies Inc
    • 6.1.7 Baxter (Hill-Rom Holdings)
    • 6.1.8 Schiller AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!